Guidance for industry : criteria for safety and efficacy evaluation of oxygen therapeutics as red blood cell substitutes.
| Corporate Author: | |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,
[2004]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS112940 |
Internet
https://purl.fdlp.gov/GPO/LPS112940Available Online
| Call Number: |
HE 20.4802:SA 1 |
|
|---|---|---|
| Call Number | Status | Get It |
| HE 20.4802:SA 1 | Available | |